January 2nd, 2011 - Volume 25 - Issue 1
pp: 1-121

Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine

Papagno, Laura; Alter, Galit; Assoumou, Lambert; More

AIDS. 25(1):27-36, January 2nd, 2011.

A randomized crossover study to compare efavirenz and etravirine treatment

Nguyen, Alain; Calmy, Alexandra; Delhumeau, Cécile; More

AIDS. 25(1):57-63, January 2nd, 2011.

A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine

Waters, Laura; Fisher, Martin; Winston, Alan; More

AIDS. 25(1):65-71, January 2nd, 2011.

Concise Communication

Alpha interferon administration during structured interruptions of combination antiretroviral therapy in patients with chronic HIV-1 infection: INTERVAC ANRS 105 trial

Boué, François; Reynes, Jacques; Rouzioux, Christine; More

AIDS. 25(1):115-118, January 2nd, 2011.